Jim Wassil - 28 Oct 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: CHIEF OPERATING OFFICER
Signature: Jim Wassil, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol: PCVX
Transactions as of: 28 Oct 2024
Net transactions value: +$80,981
Form type: 4
Filing time: 29 Oct 2024, 19:41:44 UTC
Previous filing: 03 Oct 2024
Next filing: 04 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Options Exercise	$8,480	+1,585	+0.79%	$5.35	202,231	28 Oct 2024	Direct	F1
transaction	PCVX	Common Stock	Options Exercise	$72,502	+3,464	+1.7%	$20.93	205,695	28 Oct 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Options Exercise	$0	-1,585	-2%	$0.000000	77,026	28 Oct 2024	Common Stock	1,585	$5.35	Direct	F2
transaction	PCVX	Stock Option (right to buy)	Options Exercise	$0	-3,464	-3.7%	$0.000000	89,876	28 Oct 2024	Common Stock	3,464	$20.93	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares are subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024.
F2	Stock Option is fully vested and exercisable.
F3	1/48 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.